The same government that destroyed Puerto Rico’s economy and the domestic pharmaceutical industry by repealing Section 936 in 2006 is now going to tell you what heroes they are by reviving that industry. It might be easier said than done.
Consumers continue to seek out convenience that suits their fast-paced lifestyles. Consumer behavior could reverse, but it is unlikely. What's more likely is that things will only grow more intense and the demand for convenience will only grow more extreme. Fast-moving consumer goods and pharmaceutical products benefit from the cost-to-performance ratio advantage offered by rigid plastics manufacturing.
Blister Packaging for Certain Immediate Release Opioid Analgesics for Treatment of Acute Pain – Docket No. FDA-2019-N-1845 as it relates to opioid packaging, and recently passed Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients (SUPPORT) Act, passed in late 2018.
The global pharmaceutical packaging market is set to grow over 5% year-over-year in 2019, and bottles will remain highly sought after, followed by blisters, vials and ampoules.
According to a report by Research and Markets, pharmaceutical packaging accounted for $70.16 billion in 2017 and is expected to reach $149.25 billion by 2026, growing at a CAGR of 8.75 percent during the forecast period.
Moisture management in pharmaceutical packaging is a necessity; tablets and capsules in bottles with commonplace solutions like sachet or canister desiccants come to mind. But before considering package designs and desiccant options, it is helpful to look at the sources of moisture for these drug delivery products.
